版本:
中国

BRIEF-Baxter International says received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

May 3 Baxter International Inc

* Baxter International Inc - received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

* Baxter International Inc - Baxter plans to have first patient on therapy with new system, as part of a clinical trial in 2018

* Baxter International Inc - regulatory submission is expected in 2019 for new peritoneal dialysis technology Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐